Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jul;37(7):9001-7.
doi: 10.1007/s13277-015-4578-5. Epub 2016 Jan 13.

miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma

Affiliations
Free article

miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma

Shuguang Zhou et al. Tumour Biol. 2016 Jul.
Free article

Abstract

MicroRNAs (miRNAs) are a new class of prognostic and diagnostic biomarkers for many cancers. Recent studies have shown that miRNAs are highly stable in plasma/serum. The aim of this study was to investigate the role of miR-421 in osteosarcoma. We found that the serum expression levels of miR-421 were significantly higher in osteosarcoma patients than those in healthy volunteers. Moreover, miR-421 expression was significantly higher in osteosarcoma tissues compared with that in the adjacent normal tissues. Meanwhile, the expression of miR-421 was upregulated in 90 % (36/40) osteosarcoma tissues compared to non-tumor tissues. More importantly, the expression levels of miR-421 in osteosarcoma tissues were correlated with those in patients' serum. In addition, patients with high miR-421 expression had shorter overall survival (OS) than those with low expressions. We also found that overexpression of miR-421 promoted osteosarcoma cell line MG-63 proliferation, migration, and invasion. In conclusion, miR-421 expression levels were upregulated in osteosarcoma tissue and serum and it may be a useful marker for diagnosis of osteosarcoma.

Keywords: Invasion; MicroRNAs; Osteosarcoma; Serum miRNA; miR-421.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Cancer Biomark. 2012;12(4):199-204 - PubMed
    1. Circulation. 2012 Aug 14;126(7):840-50 - PubMed
    1. Oncol Res. 2012;20(5-6):197-203 - PubMed
    1. Mol Med Rep. 2012 Jun;5(6):1514-20 - PubMed
    1. Cancer Res. 2012 Apr 1;72(7):1865-77 - PubMed

LinkOut - more resources